EYLEA® (aflibercept) INJECTION

A selection of global experts in ophthalmology

Prepared and Sponsored by Bayer Healthcare Pharmaceuticals Inc.

Replay
Cancel

Your 25-second video preview has ended.

to continue watching, please Log In or Register:


Log in / Register

Now Playing:

Treat-and-extend with anti-VEGFs: Data from clinical trials and the real world

Mr. Praveen Patel discusses how the implementation of a treat and extend regimen when administering anti-VEGFs provides benefits to both patients and service providers.

Mr Praveen Patel is Consultant Ophthalmologist in the Medical Retina Service at Moorfields Eye Hospital, London, and Ophthalmology Specialty Lead at the National Institute for Health Research (NIHR) Clinical Research Network, North Thames, UK.
As a regional Ophthalmology Specialty Lead, Mr Patel promotes and supports ophthalmology research within NHS Trusts in the North Thames area, as well as helping to manage the national ophthalmology clinical research portfolio. One of his key clinical remits has been to deliver high-quality macular treatment services at satellite sites on behalf of Moorfields Eye Hospital with a view to optimising treatment outcomes for local patients.

Product Information »

G.MKT.SM.STH.11.2015.0796